Prescription Drug Pricing

On the Mic with David Axelrod
Podcasts On the Mic with David Axelrod
The Council's Joel Wood follows up with political analyst David Axelrod for an e...
December 14, 2020
Runaway Freight Train
Health+Benefits Runaway Freight Train
Transparency alone isn’t enough to lower drug costs, but it’s a critical ste...
November 13, 2020
COVID-19 Solutions Fast-Tracked
Health+Benefits COVID-19 Solutions Fast-Tracked
Gilead relinquished its orphan drug status for remdesivir shortly after receivin...
May 31, 2020
Out of Reach?
Health+Benefits Out of Reach?
New models for financing and providing rare disease treatment could make for a s...
May 31, 2020
Parsing the Drug Supply Chain
Health+Benefits Parsing the Drug Supply Chain
Q&A with Eric Levin, CEO of Scripta Insights
April 27, 2020
PBGH Drug Formulary Study
Health+Benefits PBGH Drug Formulary Study
Q&A with Lauren Vela, Senior Director of Member Value, Pacific Business Group on...
March 1, 2020
Hospitals and Insurers Team Up to Manufacture Generic Drugs
Health+Benefits Hospitals and Insurers Team Up to Manufacture Generic Drugs
Unlikely advocates support lowering prescription drug costs
February 19, 2020
What Prescription Drug Importation Could Mean for Brokers
Health+Benefits What Prescription Drug Importation Could Mean for Brokers
Q&A with David Shore, SVP, Enterprise Strategy & Risk Management at Borislow Ins...
August 14, 2019
It’s Personal
Health+Benefits It’s Personal
Can insurers and PBMs harness their combined data to truly know the patient bett...
May 24, 2019
Prescription Back-Door Discounts
Health+Benefits Prescription Back-Door Discounts
Q&A with Steve Wojcik, VP, National Business Group on Health; Caleb Alexander, c...
April 19, 2019